
The convergence of artificial intelligence (AI) and biotechnology is revolutionizing the field of medical research, with Profluent leading the charge. Using the powerful capabilities of generative AI, the company is pioneering the custom design of proteins with a level of precision previously unattainable. Traditional methods of drug discovery, often lengthy and expensive, are poised for a transformative shift thanks to